50
Medicines
Worth a lookShows low returns (0.0%), but soft demand (-45.4% this quarter) keeps it on the watch list.
Returns
Incredible0.0%return rate — above 5% kills the launch gate
Conversion
Incredible17.2%search→purchase rate — share of searches ending in a sale
Market size
Incredible$3.2M$3.2M/yr · 1.2M searches
Avg price
Great$16.03avg listing price — sweet spot $15–$100
Price range
Good$5.97–$34.09cheapest to priciest tracked listing — scored on the share inside $15–$100
Competition
Okay66%top-5 click share — leaders hold, buyers still browse
Review moat
Bad5,065avg incumbent reviews — the moat a new listing must climb
Quality gap
Bad4.8★avg incumbent rating — lower means beatable quality
Brand share
Bad99%top-5 brand share — brand-locked demand
Growth
Bad-45.4%90-day search growth — must beat 0% to launch